Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 6Observational 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 1332Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Colonic Neoplasms 534Rectal Neoplasms 472Esophageal Neoplasms 423Liver Neoplasms 320Neoplasms 264Breast Neoplasms 220Lung Neoplasms 188Gastrointestinal Neoplasms 164Cholangiocarcinoma 150Barrett Esophagus 116Prostatic Neoplasms 107Neoplasm Metastasis 105Ovarian Neoplasms 89Carcinoma, Non-Small-Cell Lung 80Anus Neoplasms 77Melanoma 72Esophageal Squamous Cell Carcinoma 71Head and Neck Neoplasms 70Disease 70Gastrointestinal Stromal Tumors 67Colorectal Neoplasms, Hereditary Nonpolyposis 67Biliary Tract Neoplasms 67Liver Cirrhosis 60Gallbladder Neoplasms 58Recurrence 57Uterine Cervical Neoplasms 56

Interventions

Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Pancreatic Cancer Resectable × Gastrointestinal × Clear all
NCT07157605 2025-09-05

SPLENDID

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Recruiting
94 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

NCT06809374 2025-02-05

Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer

Kochi University

Completed
100 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

NCT04736043 2021-02-03

Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using Organoid

Samsung Medical Center

Unknown
300 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡